Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ) | WebDisclosure

Basculer en Français

8304	Companies
115217	Keywords
55526	Articles
62573	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 03/19/2024 at 10:58, 8 months 3 days ago

Eckert & Ziegler rejoint Societas Europaea

Société Européenne Gouvernance D'Entreprise Droits Des Actionnaires Eckert & Ziegler SE Transition Juridique
BRIEF

published on 03/19/2024 at 10:58, 8 months 3 days ago

Eckert & Ziegler Transitions to Societas Europaea

Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
PRESS RELEASE

published on 03/19/2024 at 10:53, 8 months 3 days ago

Eckert & Ziegler Completes Change of Legal Form to SE
Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy

Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
PRESS RELEASE

published on 02/28/2024 at 10:00, 8 months 23 days ago

Eckert & Ziegler Extends Ga-68 Activities in Japan
Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan

Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
BRIEF

published on 02/28/2024 at 10:00, 8 months 23 days ago

Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis

Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
BRIEF

published on 02/28/2024 at 10:00, 8 months 23 days ago

Eckert & Ziegler Étend Ses Activités sur le Ga-68 au Japon en Collaboration avec Novartis

Eckert & Ziegler Imagerie Médicale Diagnostic Gallium-68 Novartis Pharma K.K.
PRESS RELEASE

published on 01/31/2024 at 14:00, 9 months 21 days ago

Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Eckert & Ziegler to supply Nucleus Radiopharma with therapeutic radioisotopes Ac-225 and Lu-177 for cancer care, enabling advancement in radiotherapies and clinical development

Cancer Care Eckert & Ziegler Nucleus Radiopharma Therapeutic Radioisotopes Radiotherapies
PRESS RELEASE

published on 01/23/2024 at 08:00, 9 months 30 days ago

Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies have signed an agreement for the supply of Actinium-225 (Ac-225), a radionuclide for developing the next generation of therapeutic radiopharmaceuticals. The agreement aims to increase access to Ac-225, which is vital for advancing the development and clinical research efforts of Full-Life Technologies.

Clinical Research Eckert & Ziegler Full-Life Technologies Actinium-225 Supply Agreement Therapeutic Radiopharmaceuticals
PRESS RELEASE

published on 10/23/2023 at 09:00, 1 year ago

Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials
PRESS RELEASE

published on 10/20/2023 at 15:40, 1 year 1 month ago

Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG

Accesswire

Published on 11/22/2024 at 09:00, 2 hours 31 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 11 hours 31 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 13 hours 26 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 13 hours 41 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 15 hours 16 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 11:21, 10 minutes ago

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 25 minutes ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/22/2024 at 11:00, 31 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 10:46, 45 minutes ago

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 09:45, 1 hour 46 minutes ago

The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!

Les Echos

Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 4 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 15 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 16 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE